World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
98
Citations
29781
World Ranking
799
National Ranking
451

Medicine

D-Index
98
Citations
29780
World Ranking
9015
National Ranking
4643

Robert B. Belshe publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert B. Belshe sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 300 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Robert B. Belshe D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert B. Belshe sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 98 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2003 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Robert B. Belshe is affiliated with Saint Louis University in the United States and specializes in medicine with a focus on immunology and microbiology. Their research spans several subfields, including epidemiology, immunology, genetics, virology, and agronomy and crop science.

The scientist's work predominantly addresses topics related to influenza virus research studies and respiratory viral infections research. Additional areas of focus include herpesvirus infections and treatments, poxvirus research and outbreaks, virus-based gene therapy research, pneumonia and respiratory infections, and immune response and inflammation.

Robert B. Belshe has published extensively in a range of journals. Frequent publication venues include:

  • The Journal of Infectious Diseases (5 publications)
  • Aging Cell (2 publications)
  • The Journal of Immunology (1 publication)
  • The Lancet Infectious Diseases (1 publication)
  • Vaccines (1 publication)

Notable recent papers authored or co-authored by Belshe include:

  • "Seasonal Variability and Shared Molecular Signatures of Inactivated Influenza Vaccination in Young and Older Adults," 2020, The Journal of Immunology
  • "M2-Deficient Single-Replication Influenza Vaccine-Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza Strain," 2021, The Journal of Infectious Diseases
  • "Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses," 2021, The Journal of Infectious Diseases
  • "Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults," 2022, The Journal of Infectious Diseases
  • "Failure of Herpes Simplex Virus Glycoprotein D Antibodies to Elicit Antibody-Dependent Cell-Mediated Cytotoxicity: Implications for Future Vaccines," 2022, The Journal of Infectious Diseases

Robert B. Belshe frequently collaborates with several researchers, including:

  • Tamara P. Blevins
  • Subhasis Mohanty
  • Daniel G. Chawla
  • Albert C. Shaw
  • Steven H. Kleinstein

The scientist was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 2003.

Best Publications

  • The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children

    Robert B. Belshe;Paul M. Mendelman;John Treanor;James King

  • Live attenuated versus inactivated influenza vaccine in infants and young children.

    Robert B. Belshe;Kathryn M. Edwards;Timo Vesikari;Steven V. Black

  • Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.

    Kristin L. Nichol;Paul M. Mendelman;Kenneth P. Mallon;Lisa A. Jackson

  • Age-Associated Decrease in TLR Function in Primary Human Dendritic Cells Predicts Influenza Vaccine Response

    Alexander Panda;Feng Qian;Subhasis Mohanty;David van Duin

  • Efficacy Results of a Trial of a Herpes Simplex Vaccine

    Robert B. Belshe;Peter A. Leone;David I. Bernstein;Anna Wald

  • Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1

    J R Mascola;S W Snyder;O S Weislow;S M Belay

  • Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

    Frederick G. Hayden;Robert B. Belshe;Richard D. Clover;Alan J. Hay

  • Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

    Robert B. Belshe;William C. Gruber;Paul M. Mendelman;Iksung Cho

  • Correlates of Immune Protection Induced by Live, Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine

    Robert B. Belshe;William C. Gruber;Paul M. Mendelman;Harshvardhan B. Mehta

  • Serum antibody responses after intradermal vaccination against influenza.

    Robert B. Belshe;Frances K. Newman;Joan Cannon;Carol Duane

  • Management of Influenza in Households: A Prospective, Randomized Comparison of Oseltamivir Treatment With or Without Postexposure Prophylaxis

    Frederick G. Hayden;Robert Belshe;Catalina Villanueva;Riin Lanno

  • Epidemiology, clinical presentation and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women

    David I. Bernstein;Abbie R. Bellamy;Edward W. Hook;Myron J. Levin

  • Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

    Peter F. Wright;Ruth A. Karron;Robert B. Belshe;Juliette Thompson

  • Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses.

    John J Treanor;Karen Kotloff;Robert F Betts;Robert Belshe

  • Identification of a Recombinant Live Attenuated Respiratory Syncytial Virus Vaccine Candidate That Is Highly Attenuated in Infants

    Ruth A. Karron;Peter F. Wright;Robert B. Belshe;Bhagvanji Thumar

  • Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children

    Daniel F. Hoft;Elizabeth Babusis;Shewangizaw Worku;Charles T. Spencer

  • Clinical responses to undiluted and diluted smallpox vaccine.

    Sharon E. Frey;Robert B. Couch;Carol O. Tacket;John J. Treanor

  • The Origins of Pandemic Influenza — Lessons from the 1918 Virus

    Robert B. Belshe

  • Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses

    Natalie Pica;Rong Hai;Florian Krammer;Taia T. Wang

  • Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted with MF59 Administered to Healthy Adults

    Sharon E. Frey;Michael Houghton;Stephen Coates;Sergio Abrignani

  • Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV-1MN gp120, HIV-1SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults

    Mary Lou Clements-Mann;Kent Weinhold;Thomas J. Matthews;Barney S. Graham

Frequent Co-Authors

Sharon E. Frey
Sharon E. Frey Saint Louis University
Peter F. Wright
Peter F. Wright Dartmouth College
John J. Treanor
John J. Treanor University of Rochester Medical Center
Barney S. Graham
Barney S. Graham Morehouse School of Medicine
David I. Bernstein
David I. Bernstein University of Cincinnati
Michael C. Keefer
Michael C. Keefer University of Rochester
Mary Lou Clements
Mary Lou Clements Johns Hopkins University
Daniel F. Hoft
Daniel F. Hoft Saint Louis University
Mark J. Mulligan
Mark J. Mulligan New York University
Paul M. Mendelman
Paul M. Mendelman Takeda (Japan)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers. For those interested in nursing, accelerated programs like absn programs with high acceptance rates offer a quick pathway to becoming a registered nurse. These programs balance rigorous immunology knowledge with hands-on clinical practice to prepare students effectively.

Entry-level nursing roles are accessible through programs such as best easiest lpn programs to get into, ideal for those aiming to enter healthcare swiftly. These options emphasize fundamental patient care skills while allowing students to specialize in immunological conditions over time.

For career advancement, family nurse practitioner training is crucial. The easiest fnp program can help immunology graduates develop advanced clinical competencies, enabling them to provide comprehensive care in immune-related disorders.

Lastly, mental health specialties are vital for immune system-related psychological impacts. The best pmhnp programs online offer top clinical placement rates, supporting students who wish to bridge immunology and psychiatric nursing.

Best Scientists Citing Robert B. Belshe

Trending Scientists

Recently Published Articles